Health in Democratic Republic of Congo 1,591 indicators covering health for Democratic Republic of Congo. IndicatorLatest Year10-yr change Rank Most sold brand of cigarettes - price in currency reported 1,000 2020 up 42.9% 27th Most sold brand of cigarettes - taxes as a % of price - total tax 0.5% 2020 up 85.7% 103rd Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.4% 2020 up 171.4% 26th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 34th Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 42nd Most sold brand of cigarettes - taxes as a % of price - value added 0.1% 2020 — 75th Most sold brand of cigarettes - taxes as a % of price - specific 0.0% 2020 down 100.0% 129th Most sold brand of cigarettes - price in US$ at official exchange 0.51 2020 down 34.6% 178th Number of people who cannot afford a healthy diet 97.30 million people 2024 up 17.9% 6th Number of one-year-olds who are not vaccinated against Streptococcus pneumoniae 1.63 million one-year-olds 2023 down 15.8% 4th Estimated number of children (aged 0-17 years) who have lost one or 510,000 2024 down 27.1% 7th Prevalence of wasting, weight for height, female 6.9% 2023 unchanged 20th Prevalence of wasting, weight for height, male 7.4% 2023 down 20.4% 28th Population with basic handwashing facilities at home 12.3% 2022 unchanged 99th Prevalence of severe wasting, weight for height, female 1.3% 2023 down 45.8% 26th Prevalence of severe wasting, weight for height, male 2.5% 2023 down 24.2% 14th Prevalence of overweight, weight for height, female 3.4% 2023 down 22.7% 52nd Prevalence of overweight, weight for height, male 4.1% 2023 down 8.9% 48th Prevalence of underweight, weight for age, female 22.9% 2023 up 9.0% 8th Prevalence of underweight, weight for age, male 27.0% 2023 up 5.1% 7th Prevalence of stunting, height for age, female 42.0% 2023 up 4.2% 6th Prevalence of stunting, height for age, male 47.2% 2023 up 4.7% 5th How many health warnings are approved by the law for cigarette 4 2022 unchanged 105th Tuberculosis - new and relapse cases 110,132 2011 up 65.0% 11th Diarrhea treatment 24.1% 2018 down 21.8% 82nd Percentage of principal display area mandated to be covered by health 50 2022 up 66.7% 80th Pregnant women receiving prenatal care 82.4% 2018 down 3.4% 84th Estimated number of pregnant women living with HIV needing 28,000 2025 down 9.7% 10th Percentage of principal display area mandated to be covered by health 50 2022 up 66.7% 73rd Percentage of principal display area mandated to be covered by health 50 2022 up 66.7% 80th New cases: pulmonary smear-negative 13,214 2012 up 54.7% 23rd 3.3.1 (HIV Incidence) - New HIV infections per 1,000 uninfected 0.3193 2022 up 0.2% 35th Estimated number of pregnant women living with HIV 43 2025 down 8.5% 75th The number of people with susceptibility test result for rifampicin 28,577 2021 — 10th Total number of notified TB cases 116,894 2014 up 21.4% 11th Deaths in non-state conflicts based on where they occurred, annual 143.47 % change on previous year 2025 up 243.5% 5th Mother-to-child HIV transmission rate 31.4 2024 up 1.3% 10th Smear-positive tuberculosis treatment-success rate 87.0% 2011 up 13.0% 54th The number of people with susceptibility test result for rifampicin 22.3 2021 — 136th Share of one-year-olds vaccinated against rotavirus 63.0% 2024 up 1,475.0% 91st Number of indigenous P. falciparum malaria cases 29.83 million 2024 up 137.9% 1st Number of suspected malaria cases 49.38 million 2024 up 180.3% 2nd Contraceptive prevalence, any method 25.9% 2018 up 29.0% 48th Number of malaria positive cases by microscopy 2.37 million 2024 up 24.7% 4th Number of presumed malaria cases 2.10 million 2024 — 2nd Contraceptive prevalence, any modern method 16.1% 2018 up 140.3% 55th Number of indigenous malaria cases 29.83 million 2024 up 137.9% 1st Number of confirmed malaria cases 29.83 million 2024 up 137.9% 1st Total number of malaria cases 31.93 million 2024 up 154.6% 1st Number of malaria suspects examined by microscopy 4.86 million 2024 up 68.8% 8th Retreatment cases: treatment after default 597 2012 down 31.4% 17th Retreatment cases: treatment after failure 597 2012 up 4.7% 12th Yellow fever vaccine (YFV) immunization coverage among 1-year olds 55.0% 2025 down 14.1% 29th Retreatment cases: other 2,321 2012 up 499.7% 19th Expected funding for tuberculosis versus required budget 10.70 million constant 2022 US$ 2025 up 613.2% 26th Antenatal care attendees who were positive for syphilis (%), reported 7.8% 2024 up 94.5% 2nd Preterm birth 487,473 2020 up 33.2% 7th Preterm birth rate 12.4 2020 up 0.2% 8th Number of new reported cases of human African trypanosomiasis 245 2025 down 89.6% 1st Height-for-age <-2 SD 44.7 2023 up 4.7% 6th ← Previous Page 23 of 27 Next →